» Articles » PMID: 31216562

Psychiatric-disorder-related Behavioral Phenotypes and Cortical Hyperactivity in a Mouse Model of 3q29 Deletion Syndrome

Abstract

3q29 microdeletion, a rare recurrent copy number variant (CNV), greatly confers an increased risk of psychiatric disorders, such as schizophrenia and autism spectrum disorder (ASD), as well as intellectual disability. However, disease-relevant cellular phenotypes of 3q29 deletion syndrome remain to be identified. To reveal the molecular and cellular etiology of 3q29 deletion syndrome, we generated a mouse model of human 3q29 deletion syndrome by chromosome engineering, which achieved construct validity. 3q29 deletion (Df/+) mice showed reduced body weight and brain volume and, more importantly, impaired social interaction and prepulse inhibition. Importantly, the schizophrenia-related impaired prepulse inhibition was reversed by administration of antipsychotics. These findings are reminiscent of the growth defects and neuropsychiatric behavioral phenotypes in patients with 3q29 deletion syndrome and exemplify that the mouse model achieves some part of face validity and predictive validity. Unbiased whole-brain imaging revealed that neuronal hyperactivation after a behavioral task was strikingly exaggerated in a restricted region of the cortex of Df/+ mice. We further elucidated the cellular phenotypes of neuronal hyperactivation and the reduction of parvalbumin expression in the cortex of Df/+ mice. Thus, the 3q29 mouse model provides invaluable insight into the disease-causative molecular and cellular pathology of psychiatric disorders.

Citing Articles

Search for singularity cells at the onset of brain disorders using whole-brain imaging.

Hashimoto H, Nakazawa T Biophys Physicobiol. 2024; 21(Supplemental):e211003.

PMID: 39175865 PMC: 11338687. DOI: 10.2142/biophysico.bppb-v21.s003.


Phenotypes for general behavior, activity, and body temperature in 3q29 deletion model mice.

Mori D, Ikeda R, Sawahata M, Yamaguchi S, Kodama A, Hirao T Transl Psychiatry. 2024; 14(1):138.

PMID: 38453903 PMC: 10920862. DOI: 10.1038/s41398-023-02679-w.


Cross-species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion.

Purcell R, Sefik E, Werner E, King A, Mosley T, Merritt-Garza M Sci Adv. 2023; 9(33):eadh0558.

PMID: 37585521 PMC: 10431714. DOI: 10.1126/sciadv.adh0558.


Mechanisms of copy number variants in neuropsychiatric disorders: From genes to therapeutics.

Forrest M, Penzes P Curr Opin Neurobiol. 2023; 82:102750.

PMID: 37515924 PMC: 10529795. DOI: 10.1016/j.conb.2023.102750.


Shedding light on latent pathogenesis and pathophysiology of mental disorders: The potential of iPS cell technology.

Arioka Y, Okumura H, Sakaguchi H, Ozaki N Psychiatry Clin Neurosci. 2023; 77(6):308-314.

PMID: 36929185 PMC: 11488641. DOI: 10.1111/pcn.13545.


References
1.
Vazdarjanova A, Ramirez-Amaya V, Insel N, Plummer T, Rosi S, Chowdhury S . Spatial exploration induces ARC, a plasticity-related immediate-early gene, only in calcium/calmodulin-dependent protein kinase II-positive principal excitatory and inhibitory neurons of the rat forebrain. J Comp Neurol. 2006; 498(3):317-29. DOI: 10.1002/cne.21003. View

2.
Gao R, Penzes P . Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med. 2015; 15(2):146-67. PMC: 4721588. DOI: 10.2174/1566524015666150303003028. View

3.
. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. PMC: 4112379. DOI: 10.1038/nature13595. View

4.
Hara Y, Ago Y, Higuchi M, Hasebe S, Nakazawa T, Hashimoto H . Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism. Horm Behav. 2017; 96:130-136. DOI: 10.1016/j.yhbeh.2017.09.013. View

5.
Braat S, Kooy R . The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders. Neuron. 2015; 86(5):1119-30. DOI: 10.1016/j.neuron.2015.03.042. View